Comments
Loading...
West Pharmaceutical Servs (NYSE:WST) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for West Pharmaceutical Servs (WST)?
The most recent guidance for West Pharmaceutical Servs (WST) was reported on October 24, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $6.55 to $6.75, compared to the estimated EPS of $6.51. Additionally, West Pharmaceutical Servs forecasted revenue between $2.88B and $2.91B for the quarter.
Browse guidance and forecast on all stocks.